Related Experiment Videos
Ammonia induced decrease in glial fibrillary acidic protein in cultured astrocytes
M D Norenberg1, J T Neary, L O Norenberg
1Department of Pathology, Veterans Administration Medical Center, Miami, Florida.
Journal of Neuropathology and Experimental Neurology
|July 1, 1990
Summary
Ammonium chloride exposure significantly reduced glial fibrillary acidic protein (GFAP) in astrocyte cultures, suggesting a potential mechanism for hepatic encephalopathy (HE) pathogenesis. This study highlights GFAP
Area of Science:
- Neuroscience
- Cell Biology
- Biochemistry
Background:
- Hepatic encephalopathy (HE) is associated with altered astrocyte function.
- Previous research indicates reduced glial fibrillary acidic protein (GFAP) in Alzheimer type II astrocytes in HE.
- Ammonia is a key factor in HE pathogenesis.
Purpose of the Study:
- To investigate the effect of ammonia on GFAP content in primary astrocyte cultures.
- To explore potential mechanisms for GFAP alterations in astrocytes under hyperammonemic conditions.
Main Methods:
- Primary astrocyte cultures were treated with ammonium chloride (10 mM).
- Immunocytochemical and enzyme-linked immunosorbent assay (ELISA) were used to quantify GFAP levels.
- Total cell protein was measured to assess selectivity.
Main Results:
- A significant 39% reduction in GFAP content was observed after four days of ammonium chloride treatment.
- No significant decrease in total cell protein was detected, indicating selective GFAP loss.
- These findings suggest ammonia directly impacts GFAP expression or stability in astrocytes.
Conclusions:
- Ammonia exposure leads to a selective decrease in GFAP in primary astrocyte cultures.
- This finding provides a potential cellular mechanism contributing to the neuropathology of hepatic encephalopathy.
- Further research is warranted to elucidate the precise molecular pathways involved in ammonia-induced GFAP reduction.